Phio Pharmaceuticals(PHIO) - Prospectus

Table of Contents As filed with the Securities and Exchange Commission on June 8, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PHIO PHARMACEUTICALS CORP. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) 257 Simarano Drive, Suite 101 Marlborough, Massach ...